Clinical trial
Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant…
NCT00291850 · Central European Cooperative Oncology Group, Other · Terminated
Key facts
| NCT number | NCT00291850 |
|---|---|
| Title | Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC |
| Official title | Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA Non-Small Cell Lung Cancer |
| Lead sponsor | Central European Cooperative Oncology Group, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Paclitaxel, Cisplatin, Pegfilgrastim |
| Enrollment | 50 |
| Start date | Jun 1, 2005 |
| First posted | Feb 15, 2006 |
| Last update posted | May 1, 2012 |
| Countries | Austria, Hungary, Poland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: